Active substanceSodium chlorideSodium chloride
Similar drugsTo uncover
  • Aqua-Rhinosol
    spray nazal. 
    Firm VIPS-MED, LLC     Russia
  • AquaMaster®
    spray nazal. 
    EVALAR, CJSC     Russia
  • Nazol® Aqua
    spray nazal. 
    BAYER, AO     Russia
  • Sodium chloride
    solution for injections 
    ELLARA, LTD.     Russia
  • Sodium chloride
    solution d / infusion 
  • Sodium chloride
    solution for injections 
    FARMENT FIRM, LLC     Russia
  • Sodium chloride
    solution d / infusion 
    RESERV-M, LLC     Russia
  • Sodium chloride
    solution d / infusion 
    Baxter S.L.     Spain
  • Sodium chloride
    solution in / in d / infusion 
  • Sodium chloride
    solution in / in d / infusion 
    GEMATEK, LLC     Russia
  • Sodium chloride
    solution d / infusion 
  • Sodium chloride
    solution in / in d / infusion 
  • Sodium chloride
    solution d / infusion 
    ESKOM NPK, OAO     Russia
  • Sodium chloride
    solution d / infusion 
    ATOLL, LLC     Russia
  • Sodium chloride
    solution for injections 
  • Sodium chloride
    solution w / m in / in PC 
  • Sodium chloride
    solution for injections 
    DALHIMFARM, OJSC     Russia
  • Sodium chloride
    solution d / infusion 
  • Sodium chloride
    solution d / infusion 
  • Sodium chloride
    solution w / m in / in PC 
  • Sodium chloride
    solution d / infusion 
  • Sodium chloride
    solution d / infusion 
  • Sodium chloride
    solution d / infusion 
    ABOLMED, LLC     Russia
  • Sodium chloride
    solution for injections 
    ESKOM NPK, OAO     Russia
  • Sodium chloride
    solution d / infusion 
  • Sodium chloride
    solution d / infusion 
    KRASFARMA, JSC     Russia
  • Sodium chloride
    solution d / infusion 
    AKAFARM, LLC     Russia
  • Sodium chloride
    solution d / infusion 
  • Sodium chloride
    solution d / infusion 
    FARMLEND JV, LLC     Republic of Belarus
  • Sodium chloride
    solution d / infusion 
    ALTAYVITAMINS, CJSC     Russia
  • Sodium chloride
    solution for injections 
    BIOSINTEZ, PAO     Russia
  • Sodium chloride
    solution for injections 
  • Sodium chloride
    solution for injections 
    SYNTHESIS, OJSC     Russia
  • Sodium chloride
    solution d / infusion 
  • Sodium chloride
    solution d / infusion 
    RESTER, CJSC     Russia
  • Sodium chloride
    solution d / infusion 
    AVEKSIMA, JSC     Russia
  • Sodium chloride
    solution w / m in / in PC 
  • Sodium chloride
    solution d / infusion 
    SAKHAMEDPROM, SUE     Russia
  • Sodium chloride
    solution for injections 
    Mapichem AG     Switzerland
  • Sodium chloride
    solution d / infusion 
    Kelun-Kazfarm, TOO     The Republic of Kazakhstan
  • Sodium chloride B. Brown
    solution for injections 
  • Sodium chloride Brown
    solution d / infusion 
  • Sodium chloride boufouc
    solution for injections 
    UPDATE OF PFC, CJSC     Russia
  • Sodium Chloride-Vial
    solution d / infusion 
    VIAL, LLC     Russia
  • Risosin
    spray nazal. 
    SYNTHESIS, OJSC     Russia
  • Physiodosis
    solution locally 
  • Dosage form: & nbspsolution for infusions
    Composition:

    In 1 liter of the drug contains the active substance: sodium chloride 9 g.

    Auxiliary eeufecmeo: water for injection up to 1 liter.

    Description:

    A clear, colorless solution.

    Pharmacotherapeutic group:Rehydrating agent
    ATX: & nbsp

    B.05.C.B.01   Sodium chloride

    B.05.X.A.03   Sodium chloride

    Pharmacodynamics:

    Has a detoxifying and rehydrating effect. Replenishes sodium deficiency in various pathological conditions of the body and temporarily increases the volume of fluid circulating in the vessels.

    Pharmacodynamic properties of the solution are due to the presence of sodium ions and chloride ions. A number of ions, including sodium ions, penetrate the cell membrane through various transport mechanisms, among which the sodium potassium pump (Na-K-ATPase). Sodium plays an important role in signaling in neurons, electrophysiological processes of the heart, as well as in metabolic processes in the kidneys.

    Pharmacokinetics:

    Sodium is excreted mainly by the kidneys, however, while a large amount of sodium undergoes reabsorption (renal reabsorption). A small amount of sodium is excreted with feces and with sweating.

    Indications:

    - Isotonic extracellular dehydration;

    - Hyponatremia;

    - Dilution and dissolution of parenterally administered drugs (as a base solution).

    Contraindications:

    Hypernatremia, acidosis, hyperchloremia, hypokalemia, extracellular hyperhydration; circulatory disorders threatening edema of the brain and lungs; edema of the brain, edema of the lungs, acute left ventricular failure, concomitant administration of glucocorticosteroids in large doses.

    When adding other drugs to the solution, it is necessary to take into account contraindications to these drugs.

    Carefully:

    Decompensated chronic heart failure, arterial hypertension, peripheral edema, preeclampsia, chronic renal failure (oligo-, anuria), aldosteronism and other conditions associated with sodium retention in the body.

    Pregnancy and lactation:The solution can be administered during pregnancy and lactation.
    Dosing and Administration:

    Intravenously (usually drip). The required dose can be calculated in mEqV or mmol sodium, the weight of sodium ions or the mass of sodium chloride (1 g NaCl = 394 mg, 17.1 mEq, or 17.1 mmol Na and C1).

    The dose is determined depending on the patient's condition, loss of body fluids, Na+ and C1-, age, body weight of the patient. Serum concentrations of electrolytes in plasma and urine should be carefully monitored.

    The dose of sodium chloride solution for adults is: from 500 ml to 3 liters per day.

    The dose of sodium chloride solution for children is: from 20 ml to 100 ml per day per kg of body weight (depending on age and total body weight).

    The rate of administration depends on the patient's condition.

    The recommended dose when used for dilution and dissolution of parenterally administered drugs (as a solvent base solution) is in the range of 50 ml to 250 ml per dose of the drug administered. In this case, the dose and rate of administration of the solution are determined by the recommendations for the administration of the drug administered.

    Side effects:

    Acidosis, hyperhydration, hypokalemia.

    If used correctly, undesirable effects are unlikely.

    Undesirable reactions, possibly associated with a violation of the technique of administration: febrile fever; infection at the injection site; local soreness or other reaction; venous wall irritation, venous thrombosis or phlebitis spreading from the injection site; extravasation.

    Hypervolaemia.

    When using sodium chloride solution of 0.9% as a base solution (solvent) for other drugs, the probability of side effects is determined by the properties of these drugs.

    In this case, if side effects occur, you should suspend the solution, assess the patient's condition, take adequate measures and save the remaining solution for analysis, if necessary.

    If any of the side effects listed in the manual are aggravated, or if you notice any other side effects not listed in the instructions, tell your doctor.

    Overdose:

    Symptoms:

    nausea, vomiting, diarrhea, spastic pain in the stomach, thirst, reduced salivation and tearing, sweating, fever, tachycardia, increased blood pressure, renal failure, peripheral edema, pulmonary edema, respiratory arrest, headache, dizziness, anxiety, irritability, weakness, muscle cramps and rigidity, generalized convulsions, coma and death.

    Excessive administration of a solution can to cause hypernatremia.

    Excessive intake of chloride into the body can lead to a deficit of bicarbonates and hyperchloremic acidosis.

    When used as a base solution for dilution and dissolution of other drugs, symptoms and complaints with excessive administration are most often associated with the properties of the drugs administered.

    In case of unintended excess administration of the solution, treatment should be discontinued and the patient's condition assessed.

    Treatment: symptomatic.

    Interaction:

    Not described.

    When mixed with other drugs, you need to visually check for compatibility. To do this, it is necessary to observe the resulting solution to change its color and / or precipitate, the appearance of crystals, insoluble complexes. It is also necessary to take into account the instructions for the use of added drugs.

    Special instructions:

    When carrying out any infusion, it is necessary to observe the patient's condition, clinical and biological indicators, it is especially important to evaluate plasma electrolytes. In the body of children, because of the immaturity of kidney function, sodium excretion can be slowed down. Therefore, in such patients, repeated infusions should be performed only after determining the concentration of sodium in the plasma.

    Apply only a clear solution, with no visible inclusions and if the package is not damaged. Enter directly after connecting to the infusion system.

    Do not use a series connection of plastic containers. This can lead to air embolism due to sucking in the air left in the first container, which can occur before the solution from the next container arrives.The solution should be administered with the use of sterile equipment with compliance with the rules of aseptic and antiseptic. To avoid ingress of air into the infusion system, it should be filled with a solution, releasing the residual air from the container completely. Adding other drugs to the solution can be done before or during infusion by injection into a specially designed area of ​​the container.

    As with all parenteral solutions, the compatibility of the added substances with the solution should be determined before dissolution.

    Do not apply with 0.9% sodium chloride solution preparations known to be incompatible with it. Determine the compatibility of the added drugs with the sodium chloride solution 0,9% should the doctor, checking possible changes in color and / or the appearance of sediment, insoluble complexes or crystals.

    Before adding it is necessary to determine whether the added substance is soluble and stable in water at a pH level similar to that of sodium chloride 0.9. When adding the drug, it is necessary to determine the isotonicity of the resulting solution before infusion. Before adding to the solution of the preparations, they must be thoroughly mixed in accordance with the rules of asepsis.Prepared solution should be introduced immediately after preparation, do not store!

    Adding other drugs or disrupting the technique of administration can cause fever due to the possible ingestion of pyrogens. In case of development of undesirable reactions, it is necessary to stop the solution immediately.

    Prior to the application of the solution, do not remove the container from the outer protective polypropylene / polyamide bag into which it is placed, since it maintains the sterility of the preparation.

    Instructions for the use of Viaflo® Containers (Viaflo)

    1. Opening the package.

    a. Remove the Vioflo container from the outer bag immediately before use.

    b. When tightening the container, it is necessary to check it for its integrity. If mechanical damage is found, the container should be disposed of, as sterility may be impaired.

    at. Check the solution for transparency and no inclusions. The container should be disposed of if transparency is violated or inclusions are present.

    2. Preparation for use.

    Use sterile materials to prepare and inject the solution.

    a. Hang the container by the loop to the tripod.

    b.Remove the plastic fuse from the output port located at the bottom of the container:

    - grasp one hand for a small wing on the neck of the outlet port,

    - grasp the other hand by the large wing on the lid and twist,

    - the lid will open.

    at. When staging the infusion system should adhere to the rules of antiseptics.

    d. Install the infusion system in accordance with the instructions for the connection, filling the system and introducing the solution, which are contained in the instructions to the system.

    3. Adding other drugs to the solution.

    Attention: added medications may be incompatible with the solution.

    To add before the introduction:

    a. Disinfect the area for injecting drugs on the container (port for drug administration).

    b. Using a syringe with a needle of 19 - 22 sizes (1.10 - 0.70 mm), make a puncture in this area and enter the drug.

    at. Mix the preparation thoroughly with the solution. For drugs with high density, such as potassium chloride, carefully insert the drug through the syringe, holding the container so that the drug input port is on top (upside down), then mix.

    Caution: do not store containers in which preparations have been added.

    To add the drug during the administration:

    a. Move the system clamp that regulates the supply of the solution to the "Closed" position.

    b. Disinfect the area for injecting drugs on the container (port for drug administration).

    at. Using a syringe with a needle of 19 - 22 sizes (1.10 - 0.70 mm), make a puncture in this area and enter the drug.

    Remove the container from the tripod and / or turn it upside down.

    etc. Remove air from both ports.

    e. Thoroughly mix the preparation with the solution.

    f. Return the container to its working position, move the system clamp to the "Open" position and continue the introduction.

    Dispose of the containers after a single use.

    Dispose of each unused dose.

    Do not reconnect partially used containers (regardless of the amount of solution left in it).

    Effect on the ability to drive transp. cf. and fur:

    Not described.

    Form release / dosage:

    Solution for infusion 0.9%.

    Packaging:

    By 50, 100, 250, 500 or 1000 ml into VIAFLO containers made of polyethylene, polyamide and polypropylene.

    Each container is sealed in a protective polypropylene / polyamide bag. 50 pieces or 80 pieces - 50 ml; 50 pieces or 60 pieces - 100 ml; 30 pieces or 36 pieces - 250 ml; 20 pieces or 24 pieces - 500 ml; 10 pieces or 12 pieces - 1000ml in a cardboard box together with the appropriate number of instructions for use (for health care institutions).

    Storage conditions:

    At a temperature of no higher than 25 ° C.

    I kept it out of the reach of children.

    Shelf life:

    50 ml: 15 months;

    100 ml, 250 ml, 500 ml: 24 months;

    1000 ml: 36 months.

    Do not use after the expiration date printed on the package.

    Terms of leave from pharmacies:For hospitals
    Registration number:П N011884 / 01
    Date of registration:29.12.2010 / 14.12.2012
    Expiration Date:Unlimited
    The owner of the registration certificate:Baxter S.L.Baxter S.L. Spain
    Manufacturer: & nbsp
    Representation: & nbspBaxter Baxter USA
    Information update date: & nbsp15.06.2018
    Illustrated instructions
      Instructions
      Up